WinRho Mechanism of Action WinRho is a human anti‑D immunoglobulin (RhIg) that works by Injecting IgG anti‑D antibodies into an Rh‑negative mother, Binding free fetal RhD+ red blood cells in her circulation, Marking them for clearance by the reticuloendothelial system before maternal immune cells recognize them, thereby preventing sensitization. This passive immunization eliminates the risk … Read more
Winrevair Winrevair is a novel inhaled long‑acting β₂‑agonist (LABA) developed for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Pre‑clinical studies and early phase trials (Phase I/II, 2025‑2026) suggest a favorable safety profile and potent bronchodilation with a rapid onset of action. Mechanism of Action Selective β₂‑adrenergic receptor agonist: Rapidly stimulates Gs‑protein‑coupled β₂ … Read more
Winlevi Winlevi is a prescription‑grade topical antifungal gel approved for the treatment of onychomycosis (nail fungal infection) caused by dermatophytes, mainly Trichophyton rubrum. The active ingredient is tavaborole, a covalent inhibitor of fungal leucyl‑tRNA synthetase. — Mechanism of Action Target: Fungal leucyl‑tRNA synthetase (LeuRS). Action: Tavaborole forms a covalent complex with the enzyme’s tRNA‑binding site, … Read more
Willow Bark Mechanism of Action Salicin, the primary active compound, is hydrolyzed to salicylic acid in the gut. Salicylic acid competitively inhibits cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2), reducing prostaglandin synthesis. Decreased prostaglandin levels lead to: ↓ pain transmission and sensitization ↓ fever (antipyretic effect) ↓ inflammatory mediator release Pharmacokinetics Parameter Approximate Value Absorption 70–90 % oral; … Read more
Widaplik Widaplik is a third‑generation, orally available angiotensin‑II receptor blocker (ARB) designed for the treatment of hypertension and chronic heart failure. It offers improved receptor selectivity, a longer half‑life, and a lower propensity for drug‑drug interactions compared with earlier ARBs. — Mechanism of Action Selective antagonism of the AT₁ receptor – Widaplik binds with high … Read more
White Mulberry White mulberry (Morus alba L.) – dried leaves and bark are used as an adjunct‑therapy for glycemic control, weight management, and cardiovascular health. — Mechanism of Action α‑Glucosidase inhibition: 1‑deoxynojirimycin (DNJ) binds competitively to intestinal disaccharidases, delaying carbohydrate breakdown and glucose absorption. α‑Amylase inhibition: Minor activity reduces post‑prandial glucose rise. Increased GLP‑1 release: … Read more
Wezlana Wezlana (generic name) is a novel, oral small‑molecule inhibitor targeting the PI3K/AKT/mTOR signaling cascade. It has demonstrated efficacy in phase II trials for metastatic breast cancer and refractory colorectal carcinoma. Mechanism of Action Selective inhibition of class I PI3K isoforms (α, β, γ) and mTORC1, blocking downstream AKT activation. Reduces phosphorylation of AKT and S6 … Read more
Westhroid Westhroid is a novel, inhaled short‑acting β2‑adrenergic agonist (SABA) approved for acute rescue therapy in bronchospastic diseases. It is available as a 90 µg/actuation dry‑powder inhaler and as a nebulized solution (0.4 mg/mL). Mechanism of Action Selective β2‑adrenergic receptor agonist that binds to β2 receptors on bronchial smooth muscle cells. Activates Gs‑protein → adenylate cyclase → … Read more
Westcort Westcort is a novel, orally‑administered α₁‑adrenoceptor antagonist with selective affinity for the α₁A‑subtype. It is primarily indicated for hypertension and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The drug combines potent vascular smooth‑muscle relaxation with mild β₁‑adrenergic blockade, providing synergistic blood‑pressure control and prostate‑smooth‑muscle relaxation. Mechanism of Action Westcort exerts … Read more
Wellbutrin XL Bupropion hydrochloride extended‑release (Wellbutrin XL) – a non‑selective monoamine reuptake inhibitor (NSMARI) primarily used for major depressive disorder (MDD) and seasonal affective disorder (SAD). Mechanism of Action Bupropion exerts its antidepressant effect by: Inhibiting dopamine (DAT) and norepinephrine (NET) transporters – increasing synaptic levels of these monoamines in key brain regions (prefrontal cortex, … Read more